Characterization of T Cell Subsets in Adult Minimal Change Disease
Minimal change disease (MCD) is a kidney disease characterized by pathology in the glomeruli. The disease has its name because...
IMpower150 study shows atezolizumab significantly improves PFS in patients with NSCLC compared with chemotherapy
Chugai Pharmaceutical has announced atezolizumab and combination of chemotherapy demonstrated a statistically significant improvement in progression free survival (PFS), one...
BiondVax, NIH sign CTA for phase 2 trial in US with universal flu vaccine
BiondVax Pharmaceuticals Ltd. has announced the signing of the clinical trial agreement (CTA) for a phase 2 clinical trial with...
RiboBio And GE Healthcare Enter Into A Strategic Partnership For Oligonucleotide Drug Development
At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life...
Arvinas And Macroceutics Establish DEL Screening Collaboration On Undruggable Targets
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, and Macroceutics, Inc., today...
ICON launches FIRECREST Pre-Screen to improve the speed and accuracy of identifying eligible patients for screening
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device...
Roche’s phase III IMpower150 study meets co-primary endpoint of progression-free survival
Roche has announced that the phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that...
Chugai Pharma’s phase III HAVEN 3 study evaluating emicizumab meets primary endpoint
Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study...
Adocia announces positive results from phase 1 study of BioChaperone Glucagon
Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of...
SQI Signs Agreement With A World-Leading Pharmaceutical Company
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.